ProPhase Labs' stock soared 506.62% to $27.48 following a 1-for-4 reverse stock split aimed at consolidating shares and boosting price per share. Other notable gainers include Inpixon (+113%), Super League Gaming (+82%) after a major Bitcoin investment, Amylyx Pharmaceuticals (+64%) with a $350M public offering, and China SXT Pharmaceuticals (+37%) after share consolidation. These gains reflect strategic corporate actions like stock consolidations, capital raising, and major investments reshaping company valuations and attracting investor interest.
Amylyx Pharmaceuticals' stock surged 54.43% after its drug avexitide showed positive Phase 3 trial results, cutting hypoglycemic events by 55% in post-bariatric patients. UBS set a $45 price target, implying a 36% upside from current levels. The stoc...
Amylyx Pharmaceuticals received a Strong Buy upgrade following successful phase 3 LUCIDITY trial results for avexitide, which reduced severe hypoglycemic events by 55% in post-bariatric hypoglycemia patients. The drug showed strong statistical signif...
